Alan Forrest Selected Research

Alan Forrest Research Topics

Disease

60	Infections 06/2021 - 12/2002
15	Neoplasms (Cancer) 02/2024 - 02/2003
12	Critical Illness (Critically Ill) 01/2018 - 12/2005
10	Breast Neoplasms (Breast Cancer) 04/2017 - 01/2017
9	Body Weight (Weight, Body) 11/2017 - 02/2003
8	Type 2 Diabetes Mellitus (MODY) 04/2017 - 02/2017
7	Pneumonia (Pneumonitis) 01/2017 - 10/2002
6	Diabetes Mellitus 04/2017 - 09/2007
6	Bacteremia 02/2012 - 06/2004
4	Neutropenia 02/2024 - 04/2017
4	Respiratory Tract Infections (Respiratory Tract Infection) 06/2021 - 01/2004
4	Cystic Fibrosis (Mucoviscidosis) 06/2021 - 09/2009
4	Substance-Related Disorders (Drug Abuse) 06/2011 - 03/2007
4	Acquired Immunodeficiency Syndrome (AIDS) 05/2007 - 06/2003
3	Healthcare-Associated Pneumonia 06/2021 - 12/2010
3	Bacterial Pneumonia 01/2019 - 11/2013
3	Renal Insufficiency (Renal Failure) 01/2019 - 12/2010
3	Urinary Tract Infections (Urinary Tract Infection) 01/2017 - 12/2015
3	Staphylococcal Infections 02/2013 - 12/2002
3	Endocarditis 02/2012 - 01/2010
2	Ventilator-Associated Pneumonia 06/2021 - 02/2012
2	Communicable Diseases (Infectious Diseases) 01/2019 - 09/2009
2	Pseudomonas Infections 09/2009 - 10/2005
2	Wounds and Injuries (Trauma) 12/2005 - 04/2004
1	Lymphoma (Lymphomas) 01/2020
1	Confusion (Bewilderment) 01/2019
1	Anemia 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Gram-Negative Bacterial Infections 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 11/2017
1	Insulin Resistance 04/2017
1	Intraabdominal Infections 01/2017
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Frailty 01/2016

Drug/Important Bio-Agent (IBA)

16	Anti-Bacterial Agents (Antibiotics)IBA 06/2021 - 08/2003
14	Colistin (Coly-Mycin)FDA Link 01/2019 - 09/2010
12	Vancomycin FDA LinkGeneric 03/2012 - 12/2002
11	Polymyxins (Polymyxin)IBA 06/2021 - 12/2010
10	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2019 - 03/2013
9	Insulin (Novolin)FDA Link 04/2017 - 01/2017
6	Linezolid (Zyvox)FDA Link 01/2014 - 12/2002
5	CytokinesIBA 04/2017 - 01/2017
5	CreatinineIBA 01/2017 - 02/2003
4	Irinotecan (Camptosar)FDA LinkGeneric 02/2024 - 01/2020
4	SecretagoguesIBA 04/2017 - 02/2017
4	Insulin SecretagoguesIBA 04/2017 - 02/2017
4	Tazobactam FDA LinkGeneric 04/2016 - 06/2013
4	Atazanavir Sulfate (Reyataz)FDA Link 01/2016 - 03/2007
4	efavirenz (Sustiva)FDA Link 01/2016 - 06/2003
3	Doripenem FDA Link 11/2016 - 04/2013
3	ceftolozaneIBA 04/2016 - 06/2013
3	Ceftaroline FDA Link 01/2015 - 11/2013
3	Tigecycline (Tygacil)FDA Link 02/2012 - 12/2010
3	FluoroquinolonesIBA 12/2007 - 09/2003
3	Lopinavir FDA Link 11/2007 - 03/2007
2	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 01/2022
2	BilirubinIBA 01/2022 - 01/2012
2	Anti-Infective Agents (Microbicides)IBA 01/2019 - 01/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2017 - 04/2017
2	CC ChemokinesIBA 04/2017 - 04/2017
2	Interleukin-7 (Interleukin 7)IBA 04/2017 - 04/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2017 - 04/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2017 - 04/2017
2	AdipokinesIBA 02/2017 - 01/2017
2	methanesulfonic acid (methanesulfonate)IBA 01/2017 - 01/2015
2	tazobactam drug combination ceftolozaneIBA 01/2017 - 09/2013
2	Ritonavir (Norvir)FDA Link 01/2016 - 10/2007
2	Amikacin (A.M.K)FDA LinkGeneric 09/2014 - 09/2009
2	Olanzapine (Zyprexa)FDA Link 01/2014 - 09/2013
2	Dihydrotachysterol (AT 10)IBA 09/2012 - 07/2012
2	Fusidic Acid (Fucithalmic)IBA 06/2011 - 05/2011
2	Staphylococcus aureus delta hemolysin proteinIBA 01/2010 - 07/2007
2	QuinolonesIBA 09/2008 - 12/2007
2	NucleosidesIBA 01/2005 - 03/2004
2	Indinavir (Crixivan)FDA Link 03/2004 - 06/2003
1	HLA-B Antigens (HLA-B)IBA 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	solithromycinIBA 01/2019
1	HematinicsIBA 01/2019
1	Epoetin Alfa (Epogen)FDA Link 01/2019
1	Hormones (Hormone)IBA 04/2017
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 04/2017
1	Topoisomerase InhibitorsIBA 01/2017
1	gepotidacinIBA 01/2017
1	Estrogen ReceptorsIBA 01/2017
1	AerosolsIBA 01/2017
1	Meropenem (Merrem)FDA LinkGeneric 01/2017
1	Piperacillin FDA LinkGeneric 04/2016
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2016

Therapy/Procedure

18	Therapeutics 02/2024 - 10/2002
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2007
4	Injections 04/2017 - 04/2017
2	Renal Dialysis (Hemodialysis) 01/2019 - 08/2013
2	Critical Care (Surgical Intensive Care) 01/2019 - 02/2003
2	Salvage Therapy 01/2019 - 01/2015
2	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2017 - 01/2017
1	Respiratory Therapy (Therapy, Respiratory) 01/2019